Robert Morgan, MD
Orthopaedic Surgery · Concord, NCNPI 1679602429
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (51.1%), travel and lodging and education — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Arthrex at 59.0% of the total. Reporting peaked in 2023 at $6,311 and has fallen 73.3% since, to $1,684 in 2025.
Across 60 payments — averaging $309.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$11K
- Peerless Surgical Inc.$4K
- Medical Device Business Services, Inc.$2K
- Stryker$1K
- Shoulder Innovations, Inc.$116
- Encore Medical, LP$90
- plus $189 from 6 others
Across 12 payments — averaging $1447.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medical Device Business Services, Inc.$17K
- AbbVie$700
What the payments were for
- Consulting fees$2,09311%
- Speaking & faculty fees$9,50051%
- Travel & lodging$3,27318%
- Food & beverage$1,4618%
- Education$2,26712%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 24 | $10,965 |
| Peerless Surgical Inc. | 18 | $3,964 |
| Medical Device Business Services, Inc. | 2 | $2,093 |
| Stryker | 4 | $1,179 |
| Shoulder Innovations, Inc. | 1 | $116 |
| Encore Medical, LP | 1 | $90 |
| Medacta USA, Inc. | 1 | $68 |
| Smith+Nephew | 2 | $53 |
| Johnson & Johnson | 2 | $27 |
| AstraZeneca | 1 | $17 |
| Zimmer Biomet | 1 | $13 |
| Electronic Waveform Lab, Inc. | 3 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$18,594 in reported general payments places this provider in the 75th percentile of 845 orthopaedic surgery providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 24 | $914 |
| Prednisone | 120 | $369 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 53 | $356 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 36 | $270 |
| Oxycodone Hcl | 51 | $230 |
| Mupirocin | 23 | $147 |
| Ibuprofen | 38 | $131 |
| Gabapentin | 36 | $114 |
| Ondansetron Hcl | 32 | $64 |
| Promethazine Hcl | 33 | $50 |
| Meloxicam | 17 | $19 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Concord
- Bradley EllisonConcord$591K
- Thomas FehringCharlotte$18.3M
- Walter BeaverCharlotte$7.4M
- Robert AndersonCharlotte$6.6M
- William JiranekDurham$6.4M
- John MasonCharlotte$5.7M
- Thomas VailDurham$5.7M
- William DavisCharlotte$5.2M
- John EllingtonCharlotte$4.9M
- Mark EasleyDurham$4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.